Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma. [electronic resource]
- European journal of medicinal chemistry Feb 2017
- 369-378 p. digital
Publication Type: Journal Article
1768-3254
10.1016/j.ejmech.2016.12.036 doi
Antineoplastic Agents--chemical synthesis Cell Line, Tumor Drug Design Glioblastoma--pathology Humans Molecular Docking Simulation Protein Conformation Protein Kinase Inhibitors--chemical synthesis Pyrimidines--chemical synthesis Structure-Activity Relationship src-Family Kinases--antagonists & inhibitors